Outcomes of transfemoral transcatheter aortic valve implantation (TAVI) and predictors of thirty-day major adverse cardiovascular events (MACE) and one-year mortality

Outcomes of transfemoral transcatheter aortic valve implantation (TAVI) and predictors of thirty-day major adverse cardiovascular events (MACE) and one-year mortality

Objective: TAVI is more frequently used to treat aortic stenosis with the mandate to have a low as possible rate of adverse events. We present our 30-day outcomes and one-year mortality and examine the factors associated with them. Methods: A prospective evaluation was performed of all patients who...

Full description

Bibliographic Details
Main Authors: Christos Eftychiou, Nicolaos Eteocleous, Ioannis Zittis, Krikor Simamonian, Antonis Ioannou, Pantelitsa Loukaidou, Aliki Ntaka, Aris Hadjigregoriou, Vasilis Vasiliades, Maria Adamou, Eleni Constantinou, Panayiotis Avraamides
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Hellenic Journal of Cardiology
Subjects:
Transcatheter Aortic Valve Implantation
TAVI outcomes
TAVI survival
TAVI MACE
Online Access:http://www.sciencedirect.com/science/article/pii/S1109966620302013

Internet

http://www.sciencedirect.com/science/article/pii/S1109966620302013

Similar Items